Request more information

Skip to main content

Search

Request more information about PICO sNPWT

ECRI. Negative Pressure Wound Therapy Capital Equipment Market Intelligence Report. June 2022.

*Through our distribution partnership with Rotech Healthcare

1: Hudson D, Adams K, Cockwill J, Smith J. Evaluation of a new Negative Pressure Wound Therapy (NPWT) suction port (RENASYS Soft Port). Poster presented at: European Wound Management Association (EWMA)2013; Copenhagen, Denmark.

2: Forlee M, Nel J, Richardson J, Rossington A, Cockwill J, Smith J. An interim analysis of device functionality and usability of RENASYS™ TOUCH - a new portable Negative Pressure Wound Therapy (NPWT) system. Poster presented at: Wounds UK2016; Harrogate, UK.

3: Hurd T, Rossington A, Trueman P, Smith J. A retrospective comparison of the performance of two negative pressure wound therapy systems in the management of wounds of mixed etiology. Adv Wound Care. 2017;6(1):33-37.

4. Russel research reference, Russell Research RENASYS Messaging Study, Final Report. May 2022. Balcom Agency, USA.

5. Carnali M, Ronchi R, Finocchi L, Spuri Capesciotti S, Paggi B. Retrospective study on the use of negative pressure wound therapy in the treatment of pilonidal cysts (sinus pilonidalis) operated on using an open technique or complicated by dehiscence of the surgery site through sepsis. Acta Vulnologica. 2016;14(1):24-39.

6. Smith & Nephew 2012.A prospective, open, non-comparative, multi-centre study to evaluate the functionality and device performance of a new Negative Pressure Wound Therapy (NPWT) suction port (RENASYS◊ _Soft Port) in the management of acute, sub-acute and chronic wounds CSR/CT/US/11/01.

7. Rahmanian-Schwarz A, Willkomm LM, Gonser P, Hirt B, Schaller HE. A novel option in negative pressure wound therapy (NPWT) for chronic and acute wound care. Burns. 2012;38(4):573-577. doi:10.1016/j.burns.2011.10.010.

Important Safety Information

The information herein is intended for healthcare professionals. RENASYS is contraindicated in the presence of untreated osteomyelitis, exposed arteries/veins/organs/nerves, necrotic tissue with eschar present, malignancy in the wound, non-enteric and unexplored fistulas, and exposed anastomotic sites. Excessive bleeding is a serious risk associated with the application of suction to wounds, which may result in death or serious injury. For full product and safety information, please see the Instructions for Use

©2023 Smith+Nephew, Inc. Trademark of Smith+Nephew. All rights reserved.
The information on this website is intended for US only.
RNWE5-38471-0223

Learn More Button

Request a demo

First name

Last name

Professional Title

Work email

Facility

Facility zip code

What type of facility do you work in?

To select multiple, hold down Ctrl (PC) or Command (Mac).

How did you hear about the RENASYS System?

I Have read and agree to the Privacy Policy and Terms of Service. I also agree to receive email communication from Smith+Nephew

Source